Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study

Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study

BACKGROUND:<br>Familial hypercholesterolaemia (FH) is an inherited lipid disorder causing premature heart disease, which is severely underdiagnosed. Improving the identification of people with FH in primary care settings would help to reduce avoidable heart attacks and early deaths. AIM:To eva...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Akyea, RK, Qureshi, N, Kai, J, de Lusignan, S, Sherlock, J, McGee, C, Weng, S
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Royal College of General Practitioners 2020

Παρόμοια τεκμήρια

Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study
ανά: Ralph K Akyea, κ.ά.
Έκδοση: (2020-11-01)

Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care
ανά: Stephen Weng, PhD, κ.ά.
Έκδοση: (2019-05-01)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
ανά: Joe Kai, κ.ά.
Έκδοση: (2021-12-01)

Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care
ανά: Ralph K. Akyea, κ.ά.
Έκδοση: (2020-10-01)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
ανά: Joe Kai, κ.ά.
Έκδοση: (2021-12-01)

Familial hypercholesterolaemia
ανά: D.J. Blom
Έκδοση: (2011-01-01)

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
ανά: Minhas, R, κ.ά.
Έκδοση: (2009)

Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study
ανά: Anis Safura Ramli, κ.ά.
Έκδοση: (2023-06-01)

Familial hypercholesterolaemia.
ανά: Gill, P, κ.ά.
Έκδοση: (2012)

Statins and familial hypercholesterolaemia.
ανά: Neil, A, κ.ά.
Έκδοση: (2009)

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
ανά: Nadeem Qureshi, κ.ά.
Έκδοση: (2023-10-01)

EASILY MISSED? Familial hypercholesterolaemia
ανά: Gill, P, κ.ά.
Έκδοση: (2012)

Familial Hypercholesterolaemia: An Updated Overall Management
ανά: Mohd Kasim, Noor Alicezah, κ.ά.
Έκδοση: (2020)

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
ανά: Vallejo-Vaz, Antonio J., κ.ά.
Έκδοση: (2020)

Familial Hypercholesterolaemia – a targeted Next Generation Sequencing panel and retrospective analysis of patients with no previously identified pathogenic variant
ανά: E. Willis, κ.ά.
Έκδοση: (2022-10-01)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
ανά: Marks, D, κ.ά.
Έκδοση: (2000)

Novel molecular therapies for the treatment of familial hypercholesterolaemia
ανά: Kerr, A
Έκδοση: (2016)

International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia
ανά: Gerald F. Watts, κ.ά.
Έκδοση: (2024-01-01)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
ανά: Anastasia V. Poznyak, κ.ά.
Έκδοση: (2022-10-01)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
ανά: Maria Elena Capra, κ.ά.
Έκδοση: (2023-06-01)

Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia
ανά: J. Cegla, κ.ά.
Έκδοση: (2023-12-01)

The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
ανά: Humphries, SE, κ.ά.
Έκδοση: (2005)

A perspective for sequencing familial hypercholesterolaemia in African Americans
ανά: Wright, Michelle L, κ.ά.
Έκδοση: (2018)

Commentary: What's so special about familial hypercholesterolaemia?
ανά: Mant, D
Έκδοση: (2009)

Recent advances in the management and implementation of care for familial hypercholesterolaemia
ανά: Nick S.R. Lan, κ.ά.
Έκδοση: (2023-08-01)

Hypercholesterolaemia treatment in a patient with family hypercholesterolaemia and myopathy due to carnitine palmitoyltransferase II deficiency with PCSK9 inhibitors
ανά: P. Luque Linero, κ.ά.
Έκδοση: (2022-04-01)

Assessment of GENinCode in the Diagnosis of Patients with Suspected Familial Hypercholesterolaemia
ανά: P.E. Carey, κ.ά.
Έκδοση: (2022-10-01)

An investigation into any correlation between Single Nucleotide Polymorphism (SNP) score and Welsh score in Familial Hypercholesterolaemia patients and those with polygenic hypercholesterolaemia
ανά: J. Webster, κ.ά.
Έκδοση: (2022-10-01)

Prevalence and management of familial hypercholesterolaemia in patients with chest pain admitted to hospital: a retrospective observational study
ανά: Merete Heitmann, κ.ά.
Έκδοση: (2024-02-01)

Inclisiran for the treatment of hypercholesterolaemia
ανά: Joel C Marrs, κ.ά.
Έκδοση: (2024-11-01)

How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition?
ανά: S.E. Humphries, κ.ά.
Έκδοση: (2023-12-01)

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
ανά: Marks, D, κ.ά.
Έκδοση: (2003)

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
ανά: Marks, D, κ.ά.
Έκδοση: (2002)

Triple-combined hypolipidaemic therapy in familial hypercholesterolaemia: clinical cases
ανά: Svetlana A. Chepurnenko, κ.ά.
Έκδοση: (2021-10-01)

Cardiovascular Disease Risk Estimation in Mutation Confirmed Familial Hypercholesterolaemia
ανά: E. Ofagbor, κ.ά.
Έκδοση: (2023-12-01)

Genetics in familial hypercholesterolaemia – from genetic research to new guidelines
ανά: Edyta Kinga Prokop, κ.ά.
Έκδοση: (2019-04-01)

Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia
ανά: Alexander R.M. Lyons, κ.ά.
Έκδοση: (2024-03-01)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
ανά: Neil, A, κ.ά.
Έκδοση: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
ανά: Neil, H, κ.ά.
Έκδοση: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
ανά: Neil, H, κ.ά.
Έκδοση: (2004)